Quanex Building Products CORP
For the period ended Jul 31, 2024. Filed Sep 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2024 · Filed Sep 6, 2024
NX$21.17-3.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows – Nine
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended | ||
|---|---|---|
| July 31, | ||
| 2024 | 2023 | |
| (In thousands) | ||
| Operating activities: | ||
| Net income | $46,976 | $55,119 |
| Adjustments to reconcile net income to cash provided by operating activities: | ||
| Depreciation and amortization | 32,999 | 31,672 |
| Stock-based compensation | 2,159 | 1,828 |
| Deferred income tax | (2,321) | 177 |
| Gain on deal contingent foreign exchange forward currency contract | (9,200) | — |
| Other, net | 886 | 2,423 |
| Changes in assets and liabilities: | ||
| Decrease in accounts receivable | 11,114 | 9,918 |
| (Increase) decrease in inventory | (183) | 23,864 |
| Decrease (increase) in other current assets | 1,646 | (439) |
| Decrease in accounts payable | (9,634) | (15,471) |
| Increase (decrease) in accrued liabilities | 948 | (5,152) |
| Decrease (increase) in income taxes receivable | 6,659 | (3,534) |
| Increase in deferred pension benefits | — | 22 |
| Increase in other long-term liabilities | 707 | 609 |
| Other, net | 577 | 1,523 |
| Cash provided by operating activities | 83,333 | 102,559 |
| Investing activities: | ||
| Business acquisition | — | (91,302) |
| Capital expenditures | (23,435) | (22,450) |
| Proceeds from disposition of capital assets | 115 | 183 |
| Cash used for investing activities | (23,320) | (113,569) |
| Financing activities: | ||
| Borrowings under credit facilities | — | 102,000 |
| Repayments of credit facility borrowings | (15,000) | (60,000) |
| Repayments of other long-term debt | (1,893) | (1,954) |
| Common stock dividends paid | (7,943) | (7,952) |
| Issuance of common stock | 573 | 753 |
| Payroll tax paid to settle shares forfeited upon vesting of stock | (1,193) | (567) |
| Purchase of treasury stock | — | (5,593) |
| Cash (used for) provided by financing activities | (25,456) | 26,687 |
| Effect of exchange rate changes on cash and cash equivalents | 935 | 2,482 |
| Increase in cash and cash equivalents | 35,492 | 18,159 |
| Cash and cash equivalents at beginning of period | 58,474 | 55,093 |
| Cash and cash equivalents at end of period | $93,966 | $73,252 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.